Literature DB >> 31160976

Revisiting a physiologically based pharmacokinetic model for cocaine with a forensic scope.

María Elena Bravo-Gómez1, Laura Nayeli Camacho-García2, Luz Alejandra Castillo-Alanís1, Miguel Ángel Mendoza-Meléndez3, Alejandra Quijano-Mateos1.   

Abstract

A whole-body permeability-rate-limited physiologically based pharmacokinetic (PBPK) model for cocaine was developed and adjusted with the pharmacokinetic data from studies with animals and reparametrized scaling to humans with the aim to predict the concentration-time profiles of the drug in blood and different tissues in humans. Estimated time course concentrations could be used as an interpretation tool by forensic toxicologists. The model estimations were compared successfully with pharmacokinetic parameters and time to peak for some effects reported in the literature. Once developed, the PBPK model was employed to predict the time course tissue concentrations reported in previous distribution studies introducing individualizing data. The heart and brain concentrations estimated by the model match adequately with the time and duration of some effects such as chronotropic and psychoactive effects, respectively. This work is the first attempt for employing PBPK modeling as a tool for forensic interpretation. Future modeling of other cocaine metabolite profiles or interaction when co-administered with other substances, such as alcohol, might be developed in the future.

Entities:  

Year:  2019        PMID: 31160976      PMCID: PMC6505388          DOI: 10.1039/c8tx00309b

Source DB:  PubMed          Journal:  Toxicol Res (Camb)        ISSN: 2045-452X            Impact factor:   3.524


  60 in total

1.  Evaluating and expressing the propagation of uncertainty in chemical fate and bioaccumulation models.

Authors:  Matthew MacLeod; Alison J Fraser; Don Mackay
Journal:  Environ Toxicol Chem       Date:  2002-04       Impact factor: 3.742

2.  Prediction of pharmacokinetics prior to in vivo studies. II. Generic physiologically based pharmacokinetic models of drug disposition.

Authors:  Patrick Poulin; Frank-Peter Theil
Journal:  J Pharm Sci       Date:  2002-05       Impact factor: 3.534

3.  Cocaine, norcocaine, ecgonine methylester and benzoylecgonine pharmacokinetics in the rat.

Authors:  B Mets; J Diaz; E Soo; S Jamdar
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

4.  Arteriovenous serum cocaine concentration difference after intravenous bolus injection and constant-rate infusions: relation to pharmacodynamic estimates in rats.

Authors:  L Sun; C E Lau
Journal:  Eur J Pharm Sci       Date:  2001-12       Impact factor: 4.384

5.  Urinary elimination of cocaine metabolites in chronic cocaine users during cessation.

Authors:  Kenzie L Preston; David H Epstein; Edward J Cone; Abraham T Wtsadik; Marilyn A Huestis; Eric T Moolchan
Journal:  J Anal Toxicol       Date:  2002-10       Impact factor: 3.367

6.  Simultaneous pharmacokinetic modeling of cocaine and its metabolites, norcocaine and benzoylecgonine, after intravenous and oral administration in rats.

Authors:  L Sun; C E Lau
Journal:  Drug Metab Dispos       Date:  2001-09       Impact factor: 3.922

7.  Elimination of cocaine and metabolites in plasma, saliva, and urine following repeated oral administration to human volunteers.

Authors:  R A Jufer; A Wstadik; S L Walsh; B S Levine; E J Cone
Journal:  J Anal Toxicol       Date:  2000-10       Impact factor: 3.367

8.  Cocaine and metabolite elimination patterns in chronic cocaine users during cessation: plasma and saliva analysis.

Authors:  E T Moolchan; E J Cone; A Wstadik; M A Huestis; K L Preston
Journal:  J Anal Toxicol       Date:  2000-10       Impact factor: 3.367

9.  Chronic continuous cocaine infusion in rats: effect on urine cocaine, ecgonine methylester and benzoylecgonine concentrations and bolus-dose cocaine pharmacokinetics.

Authors:  B Mets; E Soo; J Diaz; C Pantuck; G Singh; I A Blair
Journal:  J Pharm Pharmacol       Date:  2000-04       Impact factor: 3.765

10.  Study of the beta1 adrenergic receptor expression in human tissues: immunological approach.

Authors:  I Hellgren; C Sylvén; Y Magnusson
Journal:  Biol Pharm Bull       Date:  2000-06       Impact factor: 2.233

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.